Primary Hypercholesterolemia
Also known as: Type IIa hyperlipidaemia / Dyslipidemia (Fredrickson Type Ⅱa) / Type IIa Hypercholesterolemia / Primary Hypercholesterolaemia / Familial Hypercholesterolaemia / Familial Hypercholesterolemia / Hypercholesterolemia, Familial / Type IIa hyperlipoproteinemia / Hyperlipoproteinemia Type IIa / Fredrickson Type IIa hyperlipoproteinemia / Type IIa hyperlipoproteinaemia / Pure hypercholesterolemia / Fredrickson Type IIa hyperlipoproteinaemia / Fredrickson Type IIa hyperlipidemia / Fredrickson Type IIa hyperlipidaemia / Fredrickson Type IIa lipidemia / Fredrickson Type IIa lipidaemia / Type IIa hyperlipidemia / Type II lipidemia / Type II lipidaemia / Hyperlipoproteinemia Type II / Type II hyperlipoproteinaemia / Type II hyperlipoproteinemia / Fredrickson Type II hyperlipidaemia / Fredrickson Type II lipidemia / Fredrickson Type II hyperlipidemia / Type II hyperlipidaemia / Fredrickson Type II lipidaemia / Type II hyperlipidemia
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00381 | Amlodipine | A calcium channel blocker used to treat hypertension and angina. |
| DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB01393 | Bezafibrate | A lipid-lowering fibrate used in the management of primary and secondary hyperlipidaemia, when there is a lack of clinical improvement following lifestyle modifications or correction of the underlying disorder. |
| DB01432 | Cholestyramine | A bile acid sequestrant used as an adjunct in the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia, and for the relief of pruritus associated with partial biliary obstruction. |
| DB00375 | Colestipol | A bile acid sequestrant used as an adjunct to diet and exercise to reduce LDL-C cholesterol levels in patients with primary hypercholesterolemia. |
| DB01039 | Fenofibrate | A peroxisome proliferator receptor alpha activator used to lower LDL-C, total-C, triglycerides, and Apo B, while increasing HDL-C in hypercholesterolemia, dyslipidemia, and hypertriglyceridemia. |
| DB13873 | Fenofibric acid | A fibrate used to treat severe hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. |
| DB01095 | Fluvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB14901 | Inclisiran | A PCSK9-targeting short interfering RNA (siRNA) that lowers plasma LDL-cholesterol levels. |
| DB00227 | Lovastatin | An HMG-CoA reductase inhibitor used to lower LDL cholesterol and reduce the risk of cardiovascular disease and associated conditions, including myocardial infarction and stroke. |
| DB00627 | Niacin | A B vitamin used to treat hypertriglyceridemia and pellagra. |
| DB01098 | Rosuvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |